Drugs for Neglected Diseases initiative (DNDi)

The Drugs for Neglected Diseases initiative (DNDi), founded in 2003, develops new treatments for neglected diseases and…

Global AMR R&D Hub

The Global Antimicrobial Resistance Research and Development Hub, or Global AMR R&D Hub for short, is an initiative of…

H3D Research Centre

The H3D Research Centre is Africa's first integrated centre for drug discovery and development. Founded at the University of…

HYpharm GmbH

HYpharm GmbH and a DZIF-funded consortium are collaborating to manufacture and preclinically develop the phage lysine protein

ICE-HBV

The "International Coalition to Eliminate HBV", or ICE-HBV, has the ambitious goal of eliminating chronic hepatitis B as a…

IDT Biologika

Together with the company IDT Biologika, the DZIF is developing a vaccine against the MERS coronavirus in a consortium of…

INCATE - Incubator for Antibacterial Therapies in Europe

Multi-resistant bacteria are spreading worldwide. New antibiotics and strategies against deadly infectious diseases are…

Kumasi Centre for Collaborative Research (KCCR)

Research foci of the "Kumasi Centre for Collaborative Research in Tropical Medicine" (KCCR) in Ghana are malaria

McMaster University

McMaster University is among Canada’s most research-intensive universities and is consistently ranked in the top 20 in the…

MSD

Merck Sharp & Dohme (MSD for short) is a US pharmaceutical company. As an industry partner of the consortium INCATE